MICHAEL WILLIAMS: Open Payments
NPI 1790342426 · FREDERICKBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$729 in 34 payments from 10 companies in 2025. Trend: 2023 $996 · 2024 $742 · 2025 $729
Food & beverage: $729
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 13 | $266 |
| Boston Scientific Corporation | 6 | $172 |
| Abbott Laboratories | 4 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Averitas Pharma Inc. | 2 | $46 |
| Medtronic, Inc. | 2 | $33 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| Amgen Inc. | 1 | $21 |
| Valinor Pharma, LLC | 1 | $21 |
Products named: XTAMPZA, WaveWriter Alpha Prime 16, General - Pain Management, RELISTOR, QUTENZA, Belbuca, INCEPTIV, OCTRODE.
Industry payments across VA — which companies pay providers there.
